Breaking News, Collaborations & Alliances

Gemini Bio to Distribute Celartia Products in US

Gemini Bio adds Celartia’s cell culture products to its portfolio.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Gemini Bioproducts, a supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, a New York-based healthcare private equity firm, has formed a distribution agreement with Celartia. Effective immediately, customers can now purchase Celartia’s line of closed, single-use cell culture cassettes directly from Gemini. Columbus, OH-based Celartia manufactures the Petaka G3, a closed, single-use, disposable cell culture device that automatically regulates dissolved gas...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters